## Summary
This paper proposes MAESTRO, a self-supervised set representation model for large cytometry samples, combining set-attention, masked reconstruction, Sinkhorn OT loss, and EMA teacher-student self-distillation to produce sample-level embeddings. The problem is important and timely: learning clinically useful sample-level immune representations from variable-size sets is more meaningful than only learning cell-level embeddings, and the empirical results suggest the approach is promising.

## Strengths
- The paper addresses a meaningful and underexplored problem: **sample-level / set-level representation learning for cytometry**, rather than the more common cell-level embedding setting. This is well motivated in the introduction and is relevant for downstream clinical prediction.
- The overall architecture is technically sensible for the domain. Using **permutation-invariant/equivariant set-attention blocks**, coupled with a **permutation-invariant reconstruction loss via Sinkhorn OT**, is a coherent way to handle unordered sets of varying size.
- The paper is evaluated on a **nontrivial real cytometry collection**: 1,514 samples across 14 cohorts, with highly variable cell counts (11,829 to 1,386,520 per sample). This is a practically relevant regime rather than a toy benchmark.
- The downstream experiments cover both **global information** (diagnosis, age, sex via linear probes) and **local information proxies** (retrieval of cell-type distributions), which is the right general direction for validating sample embeddings.
- The ablation in Table 1 is useful and indicates that the proposed ingredients are not arbitrary. In particular, the full model improves over masking-only variants, and removing masked modeling hurts substantially.
- The paper uses manual gating labels only for **evaluation**, not for pretraining, which is an appropriate design choice for a self-supervised representation learning paper.

## Weaknesses

###: Fatal
None.

### Major:
- **The main biological/clinical claims are not fully established because the evaluation does not sufficiently disentangle diagnosis from cohort/site/time effects.** The paper explicitly states that the dataset spans “**14 cohorts**,” was generated at “**three locations over various time points**,” and that raw data exhibit batch effects (Section 4.1). Yet the key evidence for “clinically relevant” embeddings—diagnosis clustering in Figure 3 and linear probing in Figure 4—does not report cohort-aware or site-controlled splits, nor a stratified generalization test. Since diagnosis may be entangled with cohort or acquisition conditions, the current results do not cleanly show that the embeddings capture disease biology rather than mixed cohort structure.
- **The method description around self-distillation is internally inconsistent enough to make the core objective unclear.** Eq. (8) defines the encoder output as a single set representation, “\( \mathbf{z}=f(\mathcal{S})\in \mathbb{R}^D \),” after PMA pooling. But Eq. (14) defines the self-distillation loss as an average over elements \(x_i\in \mathcal{S}_m\), comparing \(f_s(x_i)\) and \(f_t(x_i)\), and Algorithm 3 Step 8 similarly indexes \( \mathbf{z}_s^i \) and \( \mathbf{z}_t^i \) as though the teacher/student outputs were per-element tokens. That is not compatible with the earlier set-level encoder definition. Since self-distillation is a central component and Table 1 attributes meaningful gains to it, this ambiguity materially weakens the methodological clarity and verifiability of the paper.
- **The strongest reconstruction claim is under-supported quantitatively.** The abstract states MAESTRO is “**capable of reconstructing immune profiles (cells) even when 90% are hidden**,” but the main paper supports this primarily with qualitative UMAP plots for eight held-out samples (Figure 2). The paper does define a Sinkhorn reconstruction objective, but it does not report held-out reconstruction metrics across mask rates in the main experiments. Given that masked reconstruction is a central training signal, the evidence should be more quantitative.
- **Several comparison claims are broader than what the experiments justify.** The paper repeatedly claims MAESTRO “outperforms existing approaches,” but in Section 4.4 the other set baselines are run on a random subset of 10,000 cells because they cannot handle the full set. Per the review policy, this asymmetry should not be turned into a fairness criticism against the authors when it disfavors the baselines; in fact it can strengthen the practical claim. However, the authors should phrase conclusions more precisely: the experiments support that **the full MAESTRO system is stronger in the intended large-scale cytometry regime**, but they do not isolate whether gains come from architecture, self-supervised training, or simply access to more cells.

### Minor
- **Some framing of prior methods is overstated or imprecise.** In Section 2, the paper says “Deep Sets and Set Transformer are supervised approaches,” which is not accurate: these are architectures, not inherently supervised methods. This matters because it slightly overstates novelty and may confuse readers about what exactly is new here.
- **The decoder / reconstruction description is not sufficiently concrete.** Equation (9) says the decoder applies PMA to “unpool” a single latent vector to the size of the original set, but the mechanism determining output cardinality is not clearly specified in the provided text. The high-level idea may be implementable, but the exposition leaves an important architectural detail unclear.
- **The evidence that the embeddings encode more than coarse composition shifts is suggestive rather than conclusive.** Predicting manually gated cell-type distributions from the set embedding is a useful probe, but it does not by itself demonstrate rich cell-state structure; it may mainly reflect recovery of major compositional information. The wording in Section 4.5 somewhat overstates what this experiment proves.
- **NRBM is plausible but not deeply analyzed.** The ablation suggests masking strategy matters, but the paper does not analyze when sorting by cosine similarity in raw feature space helps, or how it affects rare populations. Given the paper’s own acknowledgment of challenges with rare populations in the limitations, this deserves more scrutiny.

### Trivial
- The term “**online tokenizer**” for the EMA teacher may be somewhat confusing, since the teacher appears to provide a continuous embedding target rather than a discrete tokenization mechanism.

## Nice-to-Haves
- Add **cross-cohort / leave-one-cohort-out** or otherwise batch-controlled evaluation to better support claims of clinical relevance and generalization.
- Report **quantitative held-out reconstruction metrics**, ideally across masking rates including the claimed 90% regime.
- Include a control where **MAESTRO is also run on a 10,000-cell subset**, not because the current comparison is unfair to the authors, but to disentangle benefits from architecture/training vs. benefits from access to more cells.
- Provide **per-class diagnostic breakdowns** or confusion analyses for diagnosis prediction.
- Analyze what the embeddings capture beyond cell-type frequencies, e.g., by comparing against a simple predictor from manually gated composition vectors using the same downstream model class.
- Clarify the exact form of the self-distillation loss and decoder cardinality generation in the main text.

## Removed Points
These points are flagged to be removed, treat them with caution.

- **“Baseline comparisons are unfair because MAESTRO sees more cells than the baselines.”** Removed as a main weakness under the stated review policy. The asymmetry here disfavors the baselines, not the proposed method; this can be a stronger practical comparison rather than an unfair one. I keep only the narrower point that the authors should phrase their claims more precisely and avoid over-attributing the source of gains.
- **Generic requests for more related work.** Removed per policy.
- **Pure reproducibility nitpicks about omitted implementation details or hyperparameters.** Removed unless they directly obscure a core claim. The important retained issue is not missing hyperparameters, but the substantive inconsistency in the self-distillation objective.
- **Complaints about release/public availability of baselines or tools.** Removed per policy.
- **Pure formatting/style issues.** Removed.

## Novel Insights
The paper’s most interesting aspect is not just that it scales set representation learning to large cytometry samples, but that it tries to unify three difficult requirements at once: permutation invariance, variable cardinality, and sample-level biological semantics. The main obstacle to acceptance is therefore not lack of motivation or lack of promising signals, but a mismatch between the ambition of the claims and the evidential precision of the paper. In particular, the paper is strongest as a **promising systems-and-representation learning contribution for large cytometry sets**, but weaker as currently written as a paper establishing **clinically meaningful immune representations**. Tightening that distinction would make the work substantially more convincing.

## Suggestions
- Rewrite Section 3.2.3 and Algorithm 3 so that the self-distillation target is mathematically unambiguous: specify whether the student/teacher match a single set embedding, a distribution over latent dimensions, or per-element representations before pooling.
- Add a **cohort/site-aware evaluation protocol**. Even one leave-one-cohort-out or site-stratified analysis would materially strengthen the central claims.
- Report **held-out Sinkhorn reconstruction loss** and reconstruction performance across mask rates, especially for the 90% masking claim in the abstract.
- Tone down broad superiority claims and instead state more precisely that MAESTRO performs best **in the intended large-scale cytometry setting**.
- Clarify the decoder: explain how output set cardinality is chosen from the latent code and how PMA is used in this “unpooling” role.
- Add a targeted analysis of **rare cell populations** and how NRBM affects them.

Originality is moderate-to-good: the components are known, but their integration for very large cytometry set representation is meaningful. The research question is important. The claims are only partially supported: some empirical results are strong and promising, but the strongest biological and methodological claims are not yet fully nailed down. Experimental soundness is decent but incomplete due to likely cohort confounding and limited quantitative support for reconstruction. Writing clarity is mixed: the motivation and high-level design are clear, but the core self-distillation objective is not. Overall value to the community is real, especially for computational biology and single-cell/cytometry ML, but the paper needs sharper evaluation and clearer method specification.

## Score and Decision
**Calibration.** I compared this paper mainly against:
- **MWP9V0Ej0d (PertEval-scFM, Reject; scores 3/6/3/6)**: a single-cell evaluation paper rejected partly for limited dataset/evaluation design and fairness/interpretation concerns. MAESTRO is **stronger** than this anchor because it introduces an actual representation-learning method with promising empirical gains, not just a benchmark with notable evaluation limitations.
- **iOltCu4TPS (Evaluating Single-Cell Foundation Models for Cell Retrieval; mixed 6/3/5/8/5/3/5, treated as reject/withdrawn)**: another single-cell paper where batch/generalization/statistical issues affected confidence. MAESTRO has a clearer method contribution, but shares concerns about how much the evaluation supports broad conclusions.
- **dQ2xiSIYzp (Generalizable Human Gaussians, Accept with all 6s)**: an accepted paper with a meaningful method contribution and good empirical results, despite some clarity and validation weaknesses. MAESTRO falls **below** this anchor because its core objective is less clearly specified and its headline claims are more vulnerable to confounding.
- **vI5cjHMzP4 (scores 3/6/8/6, Reject)** as a low-end methodological anchor where limited empirical support prevented acceptance despite some solid ideas. MAESTRO is above this anchor because it has broader empirical evidence and clearer practical value.

Relative to these anchors, this paper lands in the **borderline reject** range: promising, relevant, and potentially impactful, but not yet solid enough in methodological specification and controlled evaluation to merit acceptance as-is.

**Final score: 4.5 / 10 — Reject**

MY FINAL SCORE: <pineapple>4.5</pineapple>
MY FINAL DECISION: <orange>Reject</orange>